Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2, single-arm trial evaluating the combination of carboplatin and gemcitabine with BSI-201 in platinum-resistant recurrent ovarian can…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: First Line Ovarian Cancer Treatment - Cohort Study
This document reports on a completed cohort study evaluating first-line treatment for epithelial ovarian cancer, sponsored by ARCAGY/ GINECO…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse [Phase 1, Phase 2]
Two-stage Phase 1/2 trial of lenalidomide in asymptomatic patients with recurrent ovarian cancer and rising CA-125 in late relapse has been …
-
CLINICAL_TRIALS research · 2016-03-17Clinical Trial Update: Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
An update on a clinical trial investigating predictive biomarkers for IGF1R-targeted therapy in ovarian cancer.
-
CLINICAL_TRIALS research · 2016-03-17Clinical Trial Update: DOD Long-Term Survivors of Ovarian Cancer [NA]
This clinical trial update concerns long-term survivors of ovarian cancer. The current status is unknown and no results are reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study [NA]
This completed feasibility trial evaluated MR-PET imaging for staging and operability assessment in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract [Phase 2]
A Phase 2 clinical trial evaluating a combination chemotherapy regimen in women with endometrial cancer, fallopian tube cancer, ovarian canc…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients
Completed trial update on screening for gynecologic cancers in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer).
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for the combination of ixabepilone and liposomal doxorubicin in advanced ovarian and re…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]
This clinical trial examined a combination of sorafenib and topotecan for platinum-resistant recurrent ovarian cancer in Phase 1/2. The stud…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma [Phase 2]
Phase 2 trial update assessing the efficacy, tolerability, and safety of temsirolimus in women with platinum-refractory ovarian cancer or ad…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission [Phase 2]
A Phase 2 trial of sorafenib for ovarian epithelial cancer, Fallopian tube cancer, and primary peritoneal cancer in patients in their second…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence [Phase 2]
Phase 2 study evaluating FluGlucoScan (F-fluorodeoxyglucose) in patients with known or suspected cancers; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating ADI-PEG 20 plus cisplatin in metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluates hyperthermic intraperitoneal chemotherapy (HIPEC) as first-line therapy for patients with Stage III…
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma [Phase 2]
This entry notes a Phase 2 clinical trial evaluating the combination of radiofrequency ablation and cytokine-induced killer cells for ovaria…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating imatinib mesylate in combination with docetaxel for advanced…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial assessing perifosine in combination with docetaxel in patients with relapsed epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy [NA]
This clinical trial update compares laparoscopy and laparotomy for malignant ovarian cancer, with the current status listed as unknown.
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent [Phase 1]
Phase 1 trial of activated T-cell therapy with low-dose aldesleukin and sargramostim for advanced ovarian, fallopian tube, or primary perito…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This Phase 1 trial update investigates abdominal radiation plus docetaxel for recurrent or persistent advanced ovarian, fallopian tube, or p…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) [NA]
The PERSEE feasibility study evaluating robotic endomicroscopy to better define resection strategies for digestive system cancers and ovaria…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Safety of Antioxidants During GYN Cancer Care [Phase 2]
Phase 2 clinical trial assessing the safety of antioxidant supplements during gynecologic cancer care has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]
Phase I/II study evaluating Pazopanib in combination with Cyclophosphamide for platinum-resistant recurrent epithelial ovarian cancer has co…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [Phase 1]
This is a completed Phase 1 clinical trial update for SCH-58500 in patients with fallopian tube cancer, ovarian cancer, or primary peritonea…